Home
>
National Drug Code (NDC)
>
Xyntha
Xyntha - 58394-023-03 - (antihemophilic factor (Recombinant, Plasma/Albumin-Free))
Drug Information of Xyntha
| Product NDC: | 58394-023 |
| Proprietary Name: | Xyntha |
| Non Proprietary Name: | antihemophilic factor (Recombinant, Plasma/Albumin-Free) |
| Active Ingredient(s): | & nbsp; antihemophilic factor (Recombinant, Plasma/Albumin-Free) |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Xyntha
| Product NDC: | 58394-023 |
| Labeler Name: | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA125264 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20111201 |
Package Information of Xyntha
| Package NDC: | 58394-023-03 |
| Package Description: | 1 KIT in 1 CARTON (58394-023-03) * 4 mL in 1 SYRINGE (58394-123-03) * 1 SWAB in 1 PACKET |
NDC Information of Xyntha
| NDC Code | 58394-023-03 |
| Proprietary Name | Xyntha |
| Package Description | 1 KIT in 1 CARTON (58394-023-03) * 4 mL in 1 SYRINGE (58394-123-03) * 1 SWAB in 1 PACKET |
| Product NDC | 58394-023 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | antihemophilic factor (Recombinant, Plasma/Albumin-Free) |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20111201 |
| Marketing Category Name | BLA |
| Labeler Name | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
